It’s not just consumers who would be sold short. Independent pharmacists have voiced concerns that the service could hurt their businesses. And The Wall Street Journal’s editorial board excoriated Trump’s move Wednesday as “political extortion” of drug companies, threatening them with gargantuan tariffs if they failed to cut a deal with his administration.
Eliza Orlins, a career public defender and former candidate for Manhattan district attorney who produces social media news explainers, posted a video Wednesday in which she begged her followers not to enter their personal information into the TrumpRx website. “This is one of the scariest things I’ve seen in 2025—and that’s saying a lot,” she said.
“In order to use the site, you’d have to tell the government exactly what medications you take, what conditions you have, when you refill them,” she explained, noting, “And the White House hasn’t said data they collect, how it will be stored, who gets access, or what happens when the program ends.”
